Previous research has shown that COX-2 is particularly highly expressed in bladder cancer cells, suggesting that the COX-2 promotor gene may exhibit cancer cell-selective transcriptional activity [26]. The gene discussed is PTGS2; the disease is urinary bladder carcinoma.